SpectraCure AB (SPEC)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:SpectraCure AB (SPEC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013200
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SpectraCure AB (SpectraCure) is a healthcare technology company that develops different methods for treatment planning and laser light dose management for cancer treatment. The company develops and therapy system (PDT) commercializes photodynamic with IDOSE for tumors. Its IDOSE platform allows tomographic mapping and controls the interstitial PDT treatment which is used for accurate dosimetry of internal tumors and to avoid damage to healthy tissue. SpectraCure’s IDOSE can also perform real-time adjustments to the dose plan covering the different parts of the target tissue. The company sponsors multicentre phase l/ll clinical trial for recurrent prostate cancer. SpectraCure is headquartered in Lund, Sweden.

SpectraCure AB (SPEC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SpectraCure AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
SpectraCure AB, Medical Devices Deals, 2011 to YTD 2017 9
SpectraCure AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
SpectraCure AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
SpectraCure Partners with Princess Margaret Hospital 11
SpectraCure Enters into Agreement with Larix 12
Equity Offering 13
SpectraCure Raises USD2.73 Million in IPO of Shares and Warrants 13
SpectraCure AB – Key Competitors 14
SpectraCure AB – Key Employees 15
SpectraCure AB – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
SpectraCure AB, Pharmaceuticals & Healthcare, Key Facts, 2015 2
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SpectraCure AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SpectraCure AB, Deals By Therapy Area, 2011 to YTD 2017 8
SpectraCure AB, Medical Devices Deals, 2011 to YTD 2017 9
SpectraCure AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
SpectraCure Partners with Princess Margaret Hospital 11
SpectraCure Enters into Agreement with Larix 12
SpectraCure Raises USD2.73 Million in IPO of Shares and Warrants 13
SpectraCure AB, Key Competitors 14
SpectraCure AB, Key Employees 15

★海外企業調査レポート[SpectraCure AB (SPEC)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Hub Power Co Ltd:発電所・企業SWOT分析
    The Hub Power Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Space Hellas S.A. (SPACE):企業の財務・戦略的SWOT分析
    Space Hellas S.A. (SPACE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fnm Spa:企業の戦略・SWOT・財務分析
    Fnm Spa - Strategy, SWOT and Corporate Finance Report Summary Fnm Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Dr Pepper Snapple Group Inc:企業のM&A・事業提携・投資動向
    Dr Pepper Snapple Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dr Pepper Snapple Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Teekay Corp (TK):石油・ガス:M&Aディール及び事業提携情報
    Summary Teekay Corp (Teekay) is a provider of marine transportation services to oil and gas industry. The company transports crude oil, liquefied natural gas (LNG), liquefied petroleum gas (LPG) and other petroleum products. It also offers offshore oil production, storage and offloading services. Te …
  • Hill-Rom Holdings Inc (HRC):医療機器:M&Aディール及び事業提携情報
    Summary Hill-Rom Holdings Inc (Hill-Rom) is a medical technology company that offers patient support systems, surgical solutions and front line care products. The company’s major products and services include specialty frames and surfaces, patient mobility solutions, non-invasive therapeutic product …
  • Eguana Technologies Inc. (EGT):企業の財務・戦略的SWOT分析
    Eguana Technologies Inc. (EGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sakai Chemical Industry Co Ltd (4078):企業の財務・戦略的SWOT分析
    Sakai Chemical Industry Co Ltd (4078) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Filtration Group Corp:企業の戦略的SWOT分析
    Filtration Group Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Asian Citrus Holdings Ltd (73):企業の財務・戦略的SWOT分析
    Asian Citrus Holdings Ltd (73) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • amcure GmbH-製薬・医療分野:企業M&A・提携分析
    Summary amcure GmbH (Amcure) is biopharmaceutical company which discovers and develops therapeutics for the treatment of cancer. It develops peptide-based compounds for the treatment of metastatic forms of cancer. The company’s lead candidate AMC303, is in Phase I clinical trial and used for the tre …
  • Halliburton Co (HAL):企業の財務・戦略的SWOT分析
    Halliburton Co (HAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fubon Insurance Co., Ltd.:企業の戦略的SWOT分析
    Fubon Insurance Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Arca Continental SAB de CV:戦略・SWOT・企業財務分析
    Arca Continental SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Arca Continental SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • ReAssure Ltd:企業の戦略的SWOT分析
    ReAssure Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Isuzu Motors Limited:企業の戦略・SWOT・財務情報
    Isuzu Motors Limited - Strategy, SWOT and Corporate Finance Report Summary Isuzu Motors Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Metabolomic Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Metabolomic Diagnostics Ltd (Metabolomic Diagnostics) is an early stage medical diagnostic company that develops technology to provide predictive diagnosis of pre-eclampsia in early pregnancy. The company uses metabolic profiling for investigating the low molecular weight biochemicals existi …
  • Bri-Chem Corp. (BRY):石油・ガス:M&Aディール及び事業提携情報
    Summary Bri-Chem Corp (Bri-Chem) is an oil and gas drilling fluids provider. It manufactures, blends, packs and conducts wholesale distribution of oilfield drilling, completion, stimulation and production chemical fluids. The company supplies custom blended cementing, acidizing and fracturing chemic …
  • Biosense Webster Inc-医療機器分野:企業M&A・提携分析
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson is a medical device company that offers cardiac arrhythmias products. The company designs, manufactures and markets products for diagnosis and treatment of cardiac arrhythmias. Its products comprise ablation catheters …
  • GridPoints Inc:企業の戦略的SWOT分析
    GridPoints Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆